HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

International Summit on Hematology and Blood Disorders

April 27-29, 2023 | Orlando, USA

April 27 -29, 2023 | Orlando, Florida, USA

Transplantation Biology and New Therapeutic Avenues

Transplantation Biology and New Therapeutic Avenues

A bone marrow transplant is a treatment that replaces the damaged or diseased bone marrow with healthy blood-forming stem cells. A stem cell transplant is another name for a bone marrow transplant.  For patients with hematologic malignancies, hematopoietic cell transplantation (HCT) is a life-prolonging or potentially curative therapy option. These therapeutic techniques were initially limited to younger patients due to the significant transplant-related morbidity, but they are increasingly being employed in older adults. The incidence of most hematologic malignancies rises with age, and as the population ages, so does the number of prospective older HCT candidates. Allogeneic haemopoietic stem cell transplantation (HSCT) is used to treat a limited number of individuals with a variety of malignant and non-malignant blood illnesses, as well as other immune system problems.

Committee Members
Speaker at Hematology and Blood Disorders 2023 - Stefan Gluck

Stefan Gluck

Global Medical Affairs at Celgene Corporation, United States
Speaker at Hematology and Blood Disorders 2023 - A C Matin

A C Matin

Stanford Medical School, United States
Speaker at Hematology and Blood Disorders 2023 - Mohamed Alsharedi

Mohamed Alsharedi

Markey Cancer Center at Lexington Clinic, United States
Hematology 2023 Speakers
Speaker at Hematology and Blood Disorders 2023 - Sanghoon Lee

Sanghoon Lee

Marshall University, United States
Speaker at Hematology and Blood Disorders 2023 - Brandon Lucke Wold

Brandon Lucke Wold

University of Florida, United States
Speaker at Hematology and Blood Disorders 2023 - Erin Weigel

Erin Weigel

Kedrion Biopharma, United States
Speaker at Hematology and Blood Disorders 2023 - Melika Loriamini

Melika Loriamini

University of Toronto, Canada

Submit your abstract Today

Watsapp